ARYZTA (ARYN) Investor Update summary
Event summary combining transcript, slides, and related documents.
Investor Update summary
8 Jul, 2026Financial performance and guidance
EBITDA guidance reset to at least EUR 300 million for 2025 due to slower-than-expected cost implementation and challenging market conditions, compared to €320.9m in 2024.
Organic growth guidance reiterated at low- to mid-single-digit for 2025, supported by pricing and volume.
Free cash flow for the year expected to be around EUR 100 million, aided by accelerated cost and improvement measures.
New production lines in Switzerland and Germany are ramping up as planned, not loss-making, with a major project in Perth on track for Q1 2026.
Q3 revenue data will be released as scheduled on October 20.
Leadership and governance
CEO Michael Schai steps down immediately following a mutual decision with the Board; Urs Jordi, current Chairman, is appointed as interim CEO.
Board maintains active oversight with experienced committees and a lead independent director.
Focus remains on business performance and shareholder interests, with governance structures supporting rapid response to challenges.
No immediate plans for leadership succession; current focus is on operational execution.
The Board expresses gratitude to Michael Schai for his service and emphasizes unity in the leadership transition.
Market environment and strategy
Industry remains highly competitive, with aggressive tendering and ongoing price pressure.
Company is prioritizing organic growth and operational fitness over acquisitions, while monitoring market consolidation opportunities.
Mid-term plan, including a 15% EBITDA margin target, remains intact, though margin recovery may take time.
Return of capital to shareholders will follow repayment of hybrid instruments and maintaining a 30% equity ratio.
Management emphasizes adaptability and speed in responding to evolving consumer and cost dynamics.
Latest events from ARYZTA
- Revenue fell 2.7% to €1,063.9m, with margin resilience and capital returns planned for 2027.ARYN
H1 2026 - Revenue, EBITDA, and cash flow rose; leverage improved and capital returns planned for 2026.ARYN
H2 2025 - FY2025 targets exceeded, with strong EBITDA, cash flow, and major investment in Portugal.ARYN
Q4 2025 TU - Q3 organic growth 0.8%, YTD 2.1%, FY25 targets: €300m EBITDA, €100m free cash flow.ARYN
Q3 2025 TU - Revenue and EPS rose, with margin pressured by inflation but guidance reaffirmed.ARYN
H1 2025 - Innovation-led growth, margin expansion, and strong cash flow drive ARYZTA's robust performance.ARYN
Investor Presentation - EBITDA margin rose to 14.2% and leverage fell below 3x, driven by innovation and cost discipline.ARYN
H1 2024 - Targets above-market growth and >15% EBITDA margin by 2028 through innovation and efficiency.ARYN
CMD 2025 - Midterm targets met early, with higher margins, strong cash flow, and double-digit EPS growth.ARYN
H2 2024